echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Study of Nervous System > Eur Heart J: Be careful!

    Eur Heart J: Be careful!

    • Last Update: 2021-04-13
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    capitalgazette

    capitalgazette

    Broken heart syndrome (Takotsubo syndrome, TTS) is an acute and usually reversible heart failure syndrome, usually caused by acute emotional or physical stress.


    Heartbreak syndrome (Takotsubo syndrome, TTS) Heartbreak syndrome (Takotsubo syndrome, TTS)

    TTS tends to occur in postmenopausal women, and the ratio of male to female incidence is 1:9.


    Although the potential connection between the brain and the heart has long been considered a key factor in the development of TTS, its underlying mechanism needs further clarification.


    In the study published in the European Heart Journal, the research team analyzed brain imaging scans of 104 patients (41 patients who later developed TTS and 63 patients who did not develop TTS).


    medsci.


    (1) Increased output of sympathetic nervous system and inflammation; (2) Risk of cardiovascular disease.


    The study retrospectively identified individuals who underwent clinical 18 F-FDG-PET/CT imaging (N = 104, median age 67.


    Among the subgroups with TTS, those with the highest AmygA (>mean+1 SD) developed TTS 2 years earlier than those with lower AmygA after angiography (P=0.


    18 The relationship between stress-related neurobiological activities and TTS risk on F-FDG-PET/CT images.


    In a retrospective population with a high malignancy rate, higher AmygA was associated with an increased risk of TTS.


    Speculate the neurobiological pathway between stress and Takotsubo syndrome.


    immunity

    "We have shown that TTS is not only due to rare and sad events, such as the death of a spouse or child in the classic example.


    In addition, scientists have also determined the relationship between stress-related brain activity and the individual's bone marrow activity.


    When Tawakol hopes to apply the results to the clinic, he hopes that interventions to reduce stress-related brain activity will make it more difficult to develop TTS.


    Original link:

    Azar Radfar, Shady Abohashem.


    oup.
    com/eurheartj/advance-article/doi/10.
    1093/eurheartj/ehab029/6184791" target="_blank" rel="noopener">Stress-Associated neurobiological Activity Associates with The Risk for and Timing of Subsequent Takotsubo syndrome ,oup.
    com/eurheartj/advance-article/doi/10.
    1093/eurheartj/ehab029/6184791" target="_blank" rel="noopener"> Stress-Associated neurobiological Activity Associates with The Risk for and Timing of Subsequent Takotsubo syndromeoup.
    com/eurheartj/advance-article/doi/10.
    1093/eurheartj/ehab029/6184791" target="_blank" rel="noopener"> Stress-Associated neurobiological Activity Associates with The Risk for and Timing of Subsequent Takotsubo syndromein This message
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.